Novavax
NVAX
#5751
Rank
$1.12 B
Marketcap
$6.91
Share price
0.73%
Change (1 day)
-16.75%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of September 2025 : $0.25 Billion USD

According to Novavax's latest financial reports the company's total debt is $0.25 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$0.23 B0.58%
2023-12-31$0.22 B-58.33%
2022-12-31$0.54 B21.1%
2021-12-31$0.45 B-2.99%
2020-12-31$0.46 B45.39%
2019-12-31$0.32 B0.84%
2018-12-31$0.31 B0.45%
2017-12-31$0.31 B0.45%
2016-12-31$0.31 B79985.82%
2015-12-31$0.39 M-60.42%
2014-12-31$0.99 M-46.94%
2013-12-31$1.88 M56.1%
2012-12-31$1.2 M276.56%
2011-12-31$0.32 M-20%
2010-12-31$0.4 M-17.7%
2009-12-31$0.48 M-97.88%
2008-12-31$22.9 M0.7%
2007-12-31$22.74 M-1.9%
2006-12-31$23.18 M-24.05%
2005-12-31$30.53 M-17.85%
2004-12-31$37.16 M-11.86%
2003-12-31$42.16 M1.84%
2002-12-31$41.4 M20.58%
2001-12-31$34.33 M71.69%
2000-12-31$20 M19900%
1999-12-31$0.1 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
$45.77 M-81.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$1.25 B 397.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.66 B 164.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
$0.64 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$32.63 B 12,893.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
$60.84 B 24,128.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$32.02 B 12,650.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
$1.5 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$23.86 B 9,401.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
$2.62 M-98.96%๐Ÿ‡บ๐Ÿ‡ธ USA